Navigation Links
Mindray Announces Third Quarter 2009 Financial Results
Date:11/9/2009

expenses for the third quarter of 2009 were $14.2 million, or 9.4% of total net revenues, compared to 10.0% in the third quarter of 2008 and 9.2% in the second quarter of 2009. Non-GAAP research and development expenses for the third quarter of 2009 were $13.4 million, or 8.8% of total net revenues, compared to 9.4% in the third quarter of 2008 and 8.7% in the second quarter of 2009.

Total share-based compensation expenses, which were allocated to cost of revenues and related operating expenses, were $2.6 million in the third quarter of 2009 compared to $2.6 million in the second quarter of 2009 and $2.6 million in the third quarter of 2008.

Operating income was $34.2 million in the third quarter of 2009, a 13.5% increase from $30.2 million in the third quarter of 2008. Non-GAAP operating income in the third quarter of 2009 was $40.0 million, a 6.7% increase from $37.5 million in the third quarter of 2008. Operating margin was 22.6% in the third quarter of 2009 compared to 20.6% in the third quarter of 2008 and 24.4% in the second quarter of 2009. Non-GAAP operating margin was 26.5% in the third quarter of 2009 compared to 25.6% in the third quarter of 2008 and 27.4% in the second quarter of 2009.

Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA")

Third quarter 2009 EBITDA increased 51.6% year-over-year to $60.1 million from $39.6 million in the third quarter of 2008 and increased 28.7% from $46.7 million in the second quarter of 2009.

Net Income

Net income increased 55.2% year-over-year to $43.4 million from $28.0 million in the third quarter of 2008. Non-GAAP net income increased 11.0% year-over-year to $37.4 million from $33.7 million in the third quarter of 2008. Net margin was 28.7% in the third quarter of 2009 compared to 19.1% in the third quarter of 2008 and 20.6% in the second quarter of 2009. Non-GAAP net margin was 24.7% in the third qu
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
2. Mindray to Report Third Quarter 2007 Financial Results on November 1, 2007
3. Mindray to Attend 2007 RSNA Conference in Chicago
4. Mindray to Attend 2008 CLSA Asia Investors Forum
5. Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting
6. Mindray to Report Fourth Quarter and Fiscal Year 2007 Financial Results on March 5, 2008
7. Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results
8. Mindray to Attend the 11th Credit Suisse Asian Investment Conference
9. Mindrays Laptop-size M5 and BS-200 Receive FDA Clearance
10. Mindray to Attend the JPMorgan 4th Annual China Conference
11. Mindray to Exhibit at 2008 China International Medical Equipment Fair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2010)... ... ... WASHINGTON , March 18 The following is a statement by Cheryl G. Healton , Dr PH, President and ... , , ...
(Date:3/18/2010)... Cedars-Sinai Heart Institute presented new findings on the effectiveness ... drug therapy for atrial fibrillation and the role left ... for obese patients with chronic end-stage heart failure who ... made at the American College of Cardiology,s Scientific Session ...
(Date:3/18/2010)... ... Managers Invited to Participate in Free Interactive Learning Seminar on Strategies to Reduce Risk ... Farmington, Conn. ... company serving employers, plan sponsors and health plans, today announced that the company will ...
(Date:3/18/2010)... Vice President Biden, HHS Secretary Sebelius, Speaker Pelosi, Majority Leader Reid and Union Officials , ... , , ... ... WASHINGTON ...
(Date:3/18/2010)... can be a health hazard for people over age 50, ... Journals of Gerontology Series B: Psychological and Social ... of researchers found that job insecurity increased the chance of ... County, IL. Over time, men reacted with greater physical symptoms, ...
Breaking Medicine News(10 mins):Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 2Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 3Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 5Health News:Cedars-Sinai Heart Institute physicians present findings at ACC scientific meeting 2Health News:Cedars-Sinai Heart Institute physicians present findings at ACC scientific meeting 3Health News:Nurtur Launches Quarterly Webinar Series with Presentation on the Mental Health Parity and Addiction Equity Act 2Health News:JW Sues HHS to Obtain President's Closed-Door Health Care Meeting Docs 2Health News:JW Sues HHS to Obtain President's Closed-Door Health Care Meeting Docs 3Health News:JW Sues HHS to Obtain President's Closed-Door Health Care Meeting Docs 4Health News:Looming unemployment harms older workers' health 2
... from Britain have warned the patients to be wary of ... abroad as most have not been properly tested.// ... Times, praised UK for establishing herself as a world leader ... in particular those for multiple sclerosis and cosmetic skin treatment ...
... kidney transplant in Canada can differ according to provinces, says ... Association Journal.// ,People on dialysis in Alberta were ... those in Ontario, the study conducted over a five-year period ... lesser wait times for kidneys than Ontario. ,"We ...
... person works, the greater his chances for high blood pressure, a ... colleagues at the// University of California, Irvine analyzed more than 24,000 ... study found that people who worked 40 hours a week are ... people who work under 39 hours a week. Those who work ...
... International AIDS Conference was held recently in Toronto. Around ... participated.// The conference emphasized that development of poor countries ... their territory but also in the rich countries. ... was unwise to treat people in poor countries who ...
... Stanford University has shown that the fog of alcoholism can ... September issue of Alcoholism: Clinical & Experimental Research. ... booze the brain of alcoholics do get messed up and ... ,George Fein, PhD, and colleagues studied some ...
... waiting lists for psychiatric consultation some over 12 months old ... it was claimed today.// ,Dan Neville, a Fine Gael ... made available to mental health patients. ,He said, β€œIt ... the country are in excess of 12 months for psychiatric ...
Other Medicine News:Health News:Scientists In UK Issue A Caution Over Untested Stem Cell Treatments 2Health News:Fighting AIDS – a joint venture of the rich and the poor 2Health News:Long term Sobriety can Reverse Effects of Alcohol Damage 2Health News:Psychiatric Waiting Lists Must be Cut Down 2
(Date:3/17/2010)... Investor Forum at The Grand Hyatt in New York City on Tuesday, March 23, 2010 . , ... , , ... ... Joseph W. Kaufmann , ...
(Date:3/17/2010)... announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised in full their ... million shares of its common stock at a public offering price of $7.00 per share. , ... ... , ...
(Date:3/17/2010)... efficacy of the company,s Genous Bio-engineered R stent. , ... , , ... ... Margo Klomp , M.D., of the Academic Medical ...
Breaking Medicine Technology:Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum 2Micromet Closes $80.5 Million Public Offering of Common Stock 2Micromet Closes $80.5 Million Public Offering of Common Stock 3Micromet Closes $80.5 Million Public Offering of Common Stock 4Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 2Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 3Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 4Sexual function does not continuously decline after radiation therapy treatments for prostate cancer 64170 1Sexual function does not continuously decline after radiation therapy treatments for prostate cancer 64170 2Report suggests similar effectiveness among options for managing low risk prostate cancer 64167 1Report suggests similar effectiveness among options for managing low risk prostate cancer 64167 2Report suggests similar effectiveness among options for managing low risk prostate cancer 64167 3Conference highlights impact of unsettled summer weather on UK marine life 11329 1Conference highlights impact of unsettled summer weather on UK marine life 11329 2
Lacrimal Cannulas, 19 g. shaft tapering to 23 g. cannula, straight. Overall length 37.5 mm. 5/box....
Anterior Chamber Needle, 27 g., 5 mm from bend to tip. Overall length 22 mm. 5/box....
Anterior Chamber Needle, 25 g. Angled. 9 mm angled tip. Overall length 19 mm. 5/box....
Hydrodissection / Aspiration Cannula, 25 g. Straight with U-tip. U-shaped tip allows aspiration and irrigation at the 12 o'clock position. Overall length 18 mm. 5/box....
Medicine Products: